BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Cardiac monitoring meets smartphones with Abbott's latest CE mark approval

May 9, 2017
By Omar Ford

Abiomed enrolls first patient in Impella STEMI feasibility trial

May 5, 2017
By Omar Ford

Outset brings in $76.5M to expand market penetration for all-in-one dialysis device

May 4, 2017
By Omar Ford

Genome company Wuxi Nextcode backs up 'big data' platform with $75M series B round

May 3, 2017
By Omar Ford

Health Beacons receives U.S. FDA approval for Localizer breast lesion localization system

May 2, 2017
By Omar Ford

Epic Sciences in $40M series D round to further develop liquid biopsy tests

May 1, 2017
By Omar Ford
Epic Sciences Inc. raised $40 million in a series D round, proving investors still have strong interest in the 9-year-old liquid biopsy specialist. The San Diego-based company has taken in about $85 million since it spun out of the Scripps Research Institute in 2008. Its most recent round was led by Hermed Capital. Altos Capital Partners, Domain Associates, Genomic Health Inc., Pagoda Investment, Reach Tone Ltd., RMI Partners, Sabby Capital and VI Ventures also participated in the series D financing. "As Epic has continued to grow and evolve, we see this financing round as a...
Read More

Epic Sciences in $40M series D round to further develop liquid biopsy tests

May 1, 2017
By Omar Ford
Epic Sciences Inc. raised $40 million in a series D round, proving investors still have strong interest in the 9-year-old liquid biopsy specialist. The San Diego-based company has taken in about $85 million since it spun out of the Scripps Research Institute in 2008. Its most recent round was led by Hermed Capital. Altos Capital Partners, Domain Associates, Genomic Health Inc., Pagoda Investment, Reach Tone Ltd., RMI Partners, Sabby Capital and VI Ventures also participated in the series D financing.
Read More

Collaboration is key to innovation in growing digital health care market

April 28, 2017
By Omar Ford
ATLANTA – The digital health market is growing. Taking in about $76.7 billion in 2015, the burgeoning space is sustained through partnerships. However, some smaller med-tech companies often have difficulties partnering with larger companies to foster innovation in the digital health market. Panelists at the Southeastern Medical Device Association (SEMDA) shared some insight on how start ups can get the attention of larger firms and forge a path in digital health. Panelist Omer Inan, an assistant professor of electrical and computer engineering at the Georgia Institute of Technology, said that traditionally the model in academia...
Read More

Collaboration is key to innovation in growing digital health care market

April 28, 2017
By Omar Ford
ATLANTA – The digital health market is growing. Taking in about $76.7 billion in 2015, the burgeoning space is sustained through partnerships. However, some smaller med-tech companies often have difficulties partnering with larger companies to foster innovation in the digital health market. Panelists at the Southeastern Medical Device Association (SEMDA) shared some insight on how start ups can get the attention of larger firms and forge a path in digital health.
Read More

Device hacking, cybersecurity becoming growing concerns for med-tech companies

April 27, 2017
By Omar Ford
ATLANTA – Cybersecurity threats are becoming increasingly prevalent in the med-tech industry. Large companies are not immune to these attacks and are in some cases more of a target than smaller firms. Earlier this month Abbott Laboratories Inc. received an FDA warning letter, citing vulnerabilities with its pacemakers. (See Medical Device Daily, April 17, 2017.) The Abbott Park, Ill.-based company was brought up as an example of the growing threat of cybersecurity breaches during a panel at the Southeastern Medical Device Association's (SEMDA) annual meeting, Wednesday. Panelists presented data from BBR Services that showed 56...
Read More
Previous 1 2 … 14 15 16 17 18 19 20 21 22 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 4, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • Art concept for medical research

    MicroRNAs in circulating extracellular vesicles as IPF biomarkers

    BioWorld Science
    MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing